CHRISTOPHER CLARK: Open Payments
NPI 1649641895 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 26 payments from 14 companies in 2025. Trend: 2023 $431 · 2024 $358 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Lilly USA, LLC | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Bausch Health US, LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Jornay PM, REXULTI, MOUNJARO, AUSTEDO XR, Auvelity, FANAPT, WELLBUTRIN, INGREZZA.
Industry payments across KY — which companies pay providers there.
